Noticias de AMGN_US

Mercado

Noticias del mercado

Últimas noticias sobre AMGN_US — 702 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AMGN_US ✕ 702 resultados
02/10/2026 AMGN_US — TipRanks
Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise
02/10/2026 AMGN_US — Benzinga
Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock
02/10/2026 AMGN_US — AD HOC NEWS
Amgen wins Sjogren's trial as Jefferies raises target for Amgen stock

Second-quarter revenue rose 9.50 percent to USD 10.05 billion. Amgen stock costs EUR 364.45 on Octob

02/10/2026 AMGN_US — MarketWatch
Amgen Inc. stock underperforms Friday when compared to competitors
02/10/2026 AMGN_US — Yahoo Finance
Amgen Inc. (AMGN34.SA) Stock Price, News, Quote & History
02/10/2026 AMGN_US — GuruFocus
Amgen Inc Investor Call At IASLC 2019 World Conference on Lung Cancer Transcript
01/10/2026 AMGN_US — GuruFocus
Amgen Inc (AMGN) Shares Fall 3.4% -- GF Value Says Still Overval
01/10/2026 AMGN_US — Yahoo Finance
Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Amgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior day.

01/10/2026 AMGN_US — Kalkine Media
Amgen (NASDAQ:AMGN) Scores Late-Stage Immunology Win

Amgen (NASDAQ:AMGN) enters October on a late-stage immunology readout as healthcare leads the sector rotation.

01/10/2026 AMGN_US — AD HOC NEWS
Amgen reports Phase 3 results and Amgen stock trades at EUR 371.13

Second-quarter revenue rose 9.50 percent to USD 10.05 billion. Amgen stock costs EUR 371.13 on Octob

01/10/2026 AMGN_US — TradingKey
Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know
30/09/2026 AMGN_US — Bloomberg ES ← EN
La investigación de Amgen ofrece pistas sobre la paradoja de los medicamentos para bajar de peso

Amgen Research Offers Clue to Weight-Loss Drug Paradox

30/09/2026 AMGN_US — AD HOC NEWS ES ← EN
Las acciones de Amgen cotizan a 372,83 euros tras las llamadas mixtas de los analistas

Las acciones de Amgen informaron 10.050 millones de dólares en ingresos del segundo trimestre el 4 de agosto de 2026, un aumento interanual del 9,5 por ciento.

30/09/2026 AMGN_US — Bloomberg
Amgen Research Offers Clue to Weight-Loss Drug Paradox
29/09/2026 AMGN_US — MarketWatch
Amgen Inc. stock outperforms competitors on strong trading day
29/09/2026 AMGN_US — MarketWatch
Amgen Inc. stock outperforms competitors on strong trading day
29/09/2026 AMGN_US — kalkine.ca
Amgen (NASDAQ:AMGN) Stock: Dazodalibep's Phase 3 Win Targets a Disease With No Approved Medicines
29/09/2026 AMGN_US — OpenSecrets
Amgen Inc Agencies, 2017
29/09/2026 AMGN_US — Kalkine Media
Amgen (NASDAQ:AMGN) Reports Positive Dazodalibep Data in Sjogren's

Amgen (NASDAQ:AMGN) informa resultados positivos en la última etapa de dazodalibep en Sjogren sistémico de moderado a grave

29/09/2026 AMGN_US — AD HOC NEWS
Amgen stock draws attention after a Phase 3 trial win

Amgen stock traded at USD 418.13 on September 28, 2026, while Q2 revenue reached USD 10.05 billion.

Página 4 de 36